Venous Thromboembolism

Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years

Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years

By

A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.

Platinum-Based Chemotherapies Demonstrate Similar Risk for Thromboembolic Events

Platinum-Based Chemotherapies Demonstrate Similar Risk for Thromboembolic Events

Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.

No Benefit to Extensive Cancer Screening in Unprovoked Venous Thromboembolism

No Benefit to Extensive Cancer Screening in Unprovoked Venous Thromboembolism

By

Although unprovoked VTE may be a sign of occult cancer, results of a meta-analysis showed no benefit to extensive cancer screening in these patients.

Tissue Factor May Predict for Recurrent VTE in Patients Receiving Anticoagulants

Tissue Factor May Predict for Recurrent VTE in Patients Receiving Anticoagulants

By

An evaluation of the association of tissue factor, clinical risk factors, and other biomarkers measured at the time of initial VTE with recurrent VTE helps determine their predictive value for patients at high risk.

Blood clot risk high in outpatient chemotherapy patients

By

The occurrence of venous thromboembolism (VTE) is greater than has been identified in clinical trials, according to a large-scale analysis that assessed the real-world risk.

Unsuspected PE Does Not Up Mortality Risk in Cancer Patients

Unsuspected PE Does Not Up Mortality Risk in Cancer Patients

Unsuspected PE patients also have similar risk of recurrent VTE as those with clinically suspected PE.

Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued

Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued

New guidelines for VTE apply to acute and critical patients, outpatients with cancer, and long-distance travelers.

Costly clots common in cancer

As many as 1 in 5 people risk developing a venous thromboembolism (VTE) within a year after undergoing treatment for some types of cancers, researchers reported.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs